Inotuzumab

Tax included
Inotuzumab (Humanized Anti-CD22 Recombinant Antibody) is a humanized IgG4, κ antibody that targets human CD22. Inotuzumab can be linked to a toxic agent ozogamicin as an antibody-drug conjugate (ADC). Inotuzumab can be used for the research of acute lymphoblastic leukemia and non-Hodgkin lymphoma.
MedChemExpress 
HY-P99264

Data sheet

Size
Multiple sizes
Reactivity
ADC Antibody; CD22
Application
Cancer-programmed cell death
CAS
1660159-36-3